Medical technology company Stryker last week announced the expansion of its Salt Lake City operations in a move the company said will deliver 862 new jobs and an over $615 million investment in Utah ...
If you are wondering whether Stryker at around $351 a share is still a smart buy, or if the best days are already priced in, you are not alone. This breakdown aims to unpack that question. The stock ...
Stryker (NYSE: SYK) has outperformed the market over the past 10 years by 1.46% on an annualized basis producing an average annual return of 14.57%. Currently, Stryker has a market capitalization of ...
Compared to the aggregate P/E ratio of the 55.83 in the Health Care Equipment & Supplies industry, Stryker Inc. has a lower P/E ratio of 46.32. Shareholders might be inclined to think that the stock ...
Stryker's fair value estimate has been nudged lower, slipping from about $433.19 per share to roughly $427.66 as analysts recalibrate their expectations. This slight reset reflects a modestly higher ...
Barchart on MSN
Stryker earnings preview: What to expect
Portage, Michigan-based Stryker Corporation (SYK) is a leading global medical technology company specializing in orthopaedics ...
Valued at a market cap of $148.8 billion, Stryker Corporation (SYK) is a medical device company that operates in the orthopedic, neurotechnology & spine and surgical equipment markets. The Portage, ...
Stryker Corporation (NYSE:SYK) is one of the best healthcare AI stocks to buy now. On December 11, Citi cut the price target ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results